Pharmafile Logo
Pharmafocus logo
Advanced Search

Maintaining product authenticity: The solution to a serial problem

December 6, 2021
Sales and Marketing

Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …

Feature

Sidelined or streamlined? Diabetic care and COVID-19

December 6, 2021
Sales and Marketing

The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …

Feature

TIB Molbiol develops test kits for Omicron variant detection

December 6, 2021
Sales and Marketing

TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations …

News

FDA grants Lilly’s COVID-19 antibody therapy EUA for paediatric use

December 6, 2021
Sales and Marketing

Eli Lilly has been granted an expanded Emergency Use Authorisation (EUA) for its neutralising antibody treatment, based on the safety …

News

J&J COVID-19 booster shows increase in antibody and T-cell responses, in Phase II trial

December 6, 2021
Sales and Marketing

Johnson & Johnson have announced positive results from an independent Phase II study, which reveal that a booster shot of …

News

Omicron could become dominant variant in UK within weeks, expert warns

December 6, 2021
Research and Development

Infectious diseases expert, Professor Paul Hunter, has warned that Omicron could become the UK’s dominant COVID-19 variant within weeks.The UK …

News

UK study shows Pfizer and Moderna jabs give best COVID-19 protection

December 3, 2021
Medical Communications

The Pfizer and Moderna booster vaccines have been shown to provide the best overall boost response, according to a UK …

News

WHO say Delta measures will help fight Omicron

December 3, 2021
Medical Communications

WHO officials have shared that COVID-19 health measures taken prior to the emergence of Omicron will also help combat the …

News

Researchers develop blood test for HPV-associated head and neck cancer

December 3, 2021
Medical Communications

A new blood test developed by researchers at Mass Eye and Ear and Mass General Hospital have developed a more …

News

ARASENS Phase III trial for prostate cancer treatment meets primary endpoint

December 3, 2021
Medical Communications

Orion and Bayer’s Phase III ARASENS trial has demonstrated an increase in overall survival, evaluating darolutamide in combination with docetaxel …

News

QIAGEN announces CE marking of T-cell response measuring device

December 2, 2021
Business Services

QIAGEN has launched a CE-marked version of its QuantiFEROn SARS-CoV-2 assay, which measures T-cell responses to SARS-CoV-2, and aids in …

News

UK regulator approves antibody drug which may help tackle Omicron

December 2, 2021
Research and Development

UK drug regulators have approved Xevudy (sotrovimab), a new coronavirus antibody treatment made by GlaxoSmithKline (GSK), which has been found …

News

EU bring forward launch of COVID-19 vaccine for children

December 1, 2021
Research and Development

The rollout of Pfizer and BioNTech’s COVID-19 vaccine version for children aged five to 11 years old will begin on …

News

UK Health Secretary Javid urges for more COVID-19 tests amid rising Omicron cases and vaccine developments

December 1, 2021
Research and Development

Health secretary of the UK, Sajid Javid, has urged the public to take lateral flow tests before attending parties this …

News

FDA approves new drug for identification of ovarian cancer

November 30, 2021
Manufacturing and Production

The FDA announced the approval of pafolacianine, marketed as Cytalux, a new drug which could help doctors detect ovarian cancer …

News

FDA plans fast approvals for Omicron-targeting vaccines

November 30, 2021
Manufacturing and Production

Joe Biden has directed the FDA and CDC to respond quickly to applications for vaccines or boosters to shield against …

News

NICE recommends Tagrisso (osimertinib) in England for lung cancer patients

November 30, 2021
Manufacturing and Production

AstraZeneca have announced that Tagrisso (osimertinib) is now available as an adjuvant treatment option to patients in England with completely …

News

Vaccine makers pledge to develop Omicron-effective jab

November 29, 2021
Sales and Marketing

Leading vaccine producers have shared that they are already pursuing vaccine responses to the newly-discovered coronavirus variant, Omicron. BioNTech has …

News

Nottinghamshire school sets up targeted testing for Omicron

November 29, 2021
Sales and Marketing

A school in Nottingham has set up targeted testing after a case of the new COVID-19 variant, Omicron, was detected …

News
mufid-majnun-oi20ehignd4-unsplash

WHO: unclear if Omicron causes severe disease

November 29, 2021
Sales and Marketing

WHO has shared that it is still unclear whether the recently-detected coronavirus variant Omicron is more transmissible, or causes more …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026